Sai Life Sciences Limited will host analysts and institutional investors at the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, in New York.

The company disclosed the schedule pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Officials from Sai Life Sciences are scheduled to participate in group and one-on-one meetings throughout the day.

Meeting Details

The engagement is part of the 24th Annual Global Healthcare Conference organized by Morgan Stanley. The meetings will be conducted in person and cover both group sessions and individual discussions with investors and analysts.

Regulatory Disclosures

The company stated that all discussions during the meeting will be based on publicly available information. No unpublished price-sensitive information will be shared. The schedule is subject to change due to exigencies involving participants or the company.

Investors and analysts may approach the company for clarifications regarding the discussions after the meeting. The information is also available on the company’s website.

Sai Life Sciences has scheduled its 27th Annual General Meeting for September 17, 2026. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means in compliance with SEBI and MCA circulars.

The company dispatched the Integrated Annual Report for FY26 to members with registered email addresses on August 25, 2026. Shareholders without registered emails received a letter containing a weblink to access the report and AGM notice. Newspaper advertisements confirming the dispatch were published on August 26, 2026, in Financial Express and Mana Telangana.

Agenda Items

The primary agenda for the meeting includes:

• Receiving, considering, and adopting the Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026.
• Appointing Mr. Krishnamraju Kanumuri as a director in place of his retirement by rotation. He is eligible and offers himself for re-appointment.

Mr. Kanumuri serves as the Managing Director and CEO. He received remuneration of ₹ 13,07,65,004 in FY 2025-26. He holds a bachelor's degree in chemical engineering from Mangalore University and an MBA in Finance from the University of Kansas, USA.

E-Voting Schedule

Members can exercise voting rights electronically via KFin Technologies Limited. Voting rights are reckoned based on paid-up share value as of the cut-off date.

Meeting Details

The AGM will commence at 10:30 am on Thursday, September 17, 2026. Details regarding email registration, e-voting procedures, and VC/OAVM attendance are outlined in the AGM Notice. Members holding shares in physical mode may register email addresses with KFinTech at einward.ris@kfintech.com .

Runa Karan, Company Secretary & Compliance Officer (Membership No. A13721), signed the communication dated August 26, 2026.